Cargando…
The Impact of the CTHRSSVVC Peptide Upon Experimental Models of Trypanosoma cruzi Infection
Chagas disease (CD), caused by the hemoflagellate protozoan Trypanosoma cruzi, affects more than six million people worldwide and presents an unsatisfactory therapy, based on two nitroderivatives, introduced in clinical medicine for decades. The synthetic peptide, with CTHRSSVVC sequence (PepA), mim...
Autores principales: | Leite, Gabriela Rodrigues, Batista, Denise da Gama Jaén, Mazzeti, Ana Lia, Silva, Rosemeire Aparecida, Lugão, Ademar Benévolo, Soeiro, Maria de Nazaré Correia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121062/ https://www.ncbi.nlm.nih.gov/pubmed/35601101 http://dx.doi.org/10.3389/fcimb.2022.882555 |
Ejemplares similares
-
Combined Treatment of Heterocyclic Analogues and Benznidazole upon Trypanosoma cruzi In Vivo
por: Batista, Denise da Gama Jaén, et al.
Publicado: (2011) -
Combination With Tomatidine Improves the Potency of Posaconazole Against Trypanosoma cruzi
por: Rocha-Hasler, Marianne, et al.
Publicado: (2021) -
CTHRSSVVC Peptide as a Possible Early Molecular Imaging Target for Atherosclerosis
por: Silva, Rosemeire A., et al.
Publicado: (2016) -
The Influence of Environmental Cues on the Development of Trypanosoma cruzi in Triatominae Vector
por: Melo, Raíssa de Fátima Pimentel, et al.
Publicado: (2020) -
An Evolutionary View of Trypanosoma Cruzi Telomeres
por: Ramirez, Jose Luis
Publicado: (2020)